These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35218374)

  • 21. Sustained superiority in KOOS subscores after matrix-associated chondrocyte implantation using spheroids compared to microfracture.
    Hoburg A; Niemeyer P; Laute V; Zinser W; Becher C; Kolombe T; Fay J; Pietsch S; Kuźma T; Widuchowski W; Fickert S
    Knee Surg Sports Traumatol Arthrosc; 2023 Jun; 31(6):2482-2493. PubMed ID: 36269383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injectable autologous chondrocyte implantation in acetabular cartilage defects: 2-year minimum clinical and MRI results.
    Krueger DR; Baur ADJ; Perka C; Schroeder JH
    Arch Orthop Trauma Surg; 2023 Feb; 143(2):739-747. PubMed ID: 34468836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous Chondrocyte Implantation for Bipolar Chondral Lesions in the Patellofemoral Compartment: Clinical Outcomes at a Mean 9 Years' Follow-up.
    Ogura T; Bryant T; Merkely G; Minas T
    Am J Sports Med; 2019 Mar; 47(4):837-846. PubMed ID: 30758979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation Versus Microfracture for the Treatment of Articular Cartilage Defects: A 5-Year Follow-up of a Prospective Randomized Trial.
    Yoon KH; Lee J; Park JY
    Am J Sports Med; 2024 Feb; 52(2):362-367. PubMed ID: 38230875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, radiological, and histological outcomes after the fibrin-matrix autologous chondrocyte implantation for chondral lesions of the knee in patients more than 50 years old: A prospective case series with minimum 2-year follow-up.
    Kim MK; Park JS; Jeon YM; Jeon YS
    J Orthop Surg (Hong Kong); 2020; 28(1):2309499019893509. PubMed ID: 31876240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arthroscopic gel-type autologous chondrocyte implantation presents histologic evidence of regenerating hyaline-like cartilage in the knee with articular cartilage defect.
    Yoon TH; Jung M; Choi CH; Kim HS; Lee YH; Choi YS; Kim SJ; Kim SH
    Knee Surg Sports Traumatol Arthrosc; 2020 Mar; 28(3):941-951. PubMed ID: 31240378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of autologous bone grafting in matrix-associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU).
    Weishorn J; Tischer T; Niemeyer P; Renkawitz T; Bangert Y
    Knee Surg Sports Traumatol Arthrosc; 2024 Apr; 32(4):929-940. PubMed ID: 38426599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and radiographical ten years long-term outcome of microfracture vs. autologous chondrocyte implantation: a matched-pair analysis.
    Ossendorff R; Franke K; Erdle B; Uhl M; Südkamp NP; Salzmann GM
    Int Orthop; 2019 Mar; 43(3):553-559. PubMed ID: 29909583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous minced cartilage repair for chondral and osteochondral lesions of the knee joint demonstrates good postoperative outcomes and low reoperation rates at minimum five-year follow-up.
    Runer A; Ossendorff R; Öttl F; Stadelmann VA; Schneider S; Preiss S; Salzmann GM; Hax J
    Knee Surg Sports Traumatol Arthrosc; 2023 Nov; 31(11):4977-4987. PubMed ID: 37634136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study.
    Akgun I; Unlu MC; Erdal OA; Ogut T; Erturk M; Ovali E; Kantarci F; Caliskan G; Akgun Y
    Arch Orthop Trauma Surg; 2015 Feb; 135(2):251-263. PubMed ID: 25548122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atelocollagen-associated autologous chondrocyte implantation for the repair of large cartilage defects of the knee: Results at three to seven years.
    Kaibara T; Kondo E; Matsuoka M; Iwasaki K; Onodera T; Sakamoto K; Oda Y; Tanei ZI; Momma D; Tanaka S; Iwasaki N
    J Orthop Sci; 2024 Jan; 29(1):207-216. PubMed ID: 36628847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Radiographic Outcomes After Treatment of Patellar Chondral Defects: A Systematic Review.
    Su CA; Trivedi NN; Le HT; Sivasundaram L; Maak TG; Salata MJ; Voos JE; Karns M
    Sports Health; 2021; 13(5):490-501. PubMed ID: 33885342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous chondrocyte implantation in the patella: a multicenter experience.
    Gomoll AH; Gillogly SD; Cole BJ; Farr J; Arnold R; Hussey K; Minas T
    Am J Sports Med; 2014 May; 42(5):1074-81. PubMed ID: 24595400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refixation of Large Osteochondral Fractures After Patella Dislocation Shows Better Mid- to Long-Term Outcome Compared With Debridement.
    Gesslein M; Merkl C; Bail HJ; Krutsch V; Biber R; Schuster P
    Cartilage; 2021 Dec; 13(1_suppl):966S-973S. PubMed ID: 31718260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up evaluation of autologous chondrocyte implantation for symptomatic cartilage lesions of the knee: A single-centre prospective study.
    Berruto M; Ferrua P; Pasqualotto S; Uboldi F; Maione A; Tradati D; Usellini E
    Injury; 2017 Oct; 48(10):2230-2234. PubMed ID: 28803652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cartilage defects in the patellofemoral joint with matrix-associated autologous chondrocyte implantation effectively improves pain, function, and radiological outcomes after 5-7 years.
    Eichinger M; Henninger B; Petry B; Schuster P; Herbst E; Wagner M; Rosenberger R; Mayr R
    Arch Orthop Trauma Surg; 2024 Apr; 144(4):1655-1665. PubMed ID: 38206448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation versus Microfracture for Repair of Articular Cartilage Defects: A Prospective Randomized Trial.
    Yoon KH; Yoo JD; Choi CH; Lee J; Lee JY; Kim SG; Park JY
    Cartilage; 2021 Dec; 13(1_suppl):1092S-1104S. PubMed ID: 32476445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogel-based and spheroid-based autologous chondrocyte implantation of the knee show similar 2-year functional outcomes: An analysis based on the German Cartilage Registry (KnorpelRegister DGOU).
    Bumberger A; Niemeyer P; Angele P; Wright EK; Faber SO
    Knee Surg Sports Traumatol Arthrosc; 2024 Sep; 32(9):2258-2266. PubMed ID: 38751089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arthroscopic Treatment of Patellar and Trochlear Cartilage Lesions with Matrix Encapsulated Chondrocyte Implantation versus Microfracture: Quantitative Assessment with MRI T2-Mapping and MOCART at 4-Year Follow-up.
    Olivos Meza A; Cortés González S; Ferniza Garza JJ; Pérez Jiménez FJ; Enrique VC; Ibarra C
    Cartilage; 2021 Jul; 12(3):320-332. PubMed ID: 30943755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mid- to Long-Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next-Generation Matrix-Induced Autologous Chondrocyte Implantation (MACI).
    Liu Y; Ma N; Zhao Z; Guo Q
    Orthop Surg; 2023 Feb; 15(2):549-562. PubMed ID: 36650102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.